Chitose Ogawa

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 92 publications

Phase II study of glucarpidase in Japanese patients with delayed methotrexate clearance after high-dose methotrexate therapy

Phase II study of glucarpidase in Japanese patients with delayed methotrexate clearance after high-dose methotrexate therapy

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: December 07, 2025

Prognostic Stratification of Standard Responders to Neoadjuvant Chemotherapy in Patients with Osteosarcoma Using 18F-FDG PET/CT Imaging.

Prognostic Stratification of Standard Responders to Neoadjuvant Chemotherapy in Patients with Osteosarcoma Using 18F-FDG PET/CT Imaging.

Journal: JB & JS open access
Published: November 12, 2025

Genomic Profiling of Pediatric Solid Tumors With a Dual DNA/RNA Panel: JCCG-TOP2 Study.

Genomic Profiling of Pediatric Solid Tumors With a Dual DNA/RNA Panel: JCCG-TOP2 Study.

Journal: Cancer science
Published: May 08, 2025

Incidence and age- and site-specific characteristics of osteosarcoma: a population-based study using National Cancer Registry 2016-2019.

Incidence and age- and site-specific characteristics of osteosarcoma: a population-based study using National Cancer Registry 2016-2019.

Journal: Japanese journal of clinical oncology
Published: March 25, 2025

Successful Multidisciplinary Treatment of Tracheal Lymphoepithelial Carcinoma in an Adolescent Patient.

Successful Multidisciplinary Treatment of Tracheal Lymphoepithelial Carcinoma in an Adolescent Patient.

Journal: Pediatric blood & cancer
Published: February 14, 2025

Oral beclomethasone dipropionate therapy and prognostic plasma biomarkers for gastrointestinal graft-versus-host disease.

Oral beclomethasone dipropionate therapy and prognostic plasma biomarkers for gastrointestinal graft-versus-host disease.

Journal: International journal of hematology
Published: January 17, 2025

A prospective study evaluating the safety and pharmacokinetics of ponatinib at a fixed dose in six paediatric patients with philadelphia chromosome-positive leukaemia: JCCG PedPona19 study.

A prospective study evaluating the safety and pharmacokinetics of ponatinib at a fixed dose in six paediatric patients with philadelphia chromosome-positive leukaemia: JCCG PedPona19 study.

Journal: British journal of haematology
Published: January 13, 2025

A phase 1 dose-escalation study of LY3295668 erbumine as monotherapy and in combination with topotecan and cyclophosphamide in children with relapsed/refractory neuroblastoma.

A phase 1 dose-escalation study of LY3295668 erbumine as monotherapy and in combination with topotecan and cyclophosphamide in children with relapsed/refractory neuroblastoma.

Journal: Cancer
Published: October 03, 2024

Pediatric Mesenchymal Tumor With MN1::TAF3 Fusion.

Pediatric Mesenchymal Tumor With MN1::TAF3 Fusion.

Journal: Genes, chromosomes & cancer
Published: September 12, 2024

Retrospective nationwide survey of pediatric RDD in Japan: a high prevalence of mutations in the kinase pathway genes.

Retrospective nationwide survey of pediatric RDD in Japan: a high prevalence of mutations in the kinase pathway genes.

Journal: International journal of hematology
Published: September 09, 2024

Real-world Outcomes of Commercial Tisagenlecleucel for Children, Adolescents, and Young Adults With Acute Lymphoblastic Leukemia in Japan.

Real-world Outcomes of Commercial Tisagenlecleucel for Children, Adolescents, and Young Adults With Acute Lymphoblastic Leukemia in Japan.

Journal: Transplantation and cellular therapy
Published: August 23, 2024

Phase 2 multicenter study of pegaspargase in Japanese patients with previously untreated acute lymphoblastic leukemia.

Phase 2 multicenter study of pegaspargase in Japanese patients with previously untreated acute lymphoblastic leukemia.

Journal: International journal of hematology
Published: July 22, 2024
Showing 1-12 of 92

Last Updated: 09/26/2026